Kalaris Therapeutics, Inc. (KLRS)
Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (CM) Primary NASDAQ (NMS) $
3. 58
-0.15
-4.0214%
$
87.9M Market Cap
- P/E Ratio
- Div Yield
71,654 Volume
-1.75 Eps
$ 3.73
Previous Close 
Want to track KLRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kalaris Therapeutics, Inc. (KLRS) Statistics
Valuation metrics
Market Cap 87.9M
Enterprise value 36.74M
Trailing P/E (ttm) -1.73
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 1.29
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 156.93K
Average volume (90 days) 91.51K
Price summary
52-Week low 2.14
52-Week high 11.88
Beta -
50-Day moving average 4.23
200-Day moving average 7.51
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:23
Last split Date 16 Jan 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.4%
Return on equity -0.73%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.1
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 12.14%
Book value per share (mrq) 2.89
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
